Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-24 @ 5:38 PM
Study NCT ID:
NCT04426968
Status:
COMPLETED
Last Update Posted:
2025-01-27
First Post:
2020-06-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
Sponsor:
Shanghai HEP Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-29
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-09
First Submit QC Date:
None
Study First Post Date:
2020-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-22
Last Update Post Date:
2025-01-27
Last Update Post Date Type:
ACTUAL